Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death

Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are current...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amy L. Clark, Kohsuke Kanekura, Zeno Lavagnino, Larry D. Spears, Damien Abreu, Jana Mahadevan, Takuya Yagi, Clay F. Semenkovich, David W. Piston, Fumihiko Urano
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:be8e2bac311c4815b5a158b712b3a6a3
record_format dspace
spelling oai:doaj.org-article:be8e2bac311c4815b5a158b712b3a6a32021-12-02T12:32:52ZTargeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death10.1038/s41598-017-05935-42045-2322https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a32017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05935-4https://doaj.org/toc/2045-2322Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are currently no treatments targeting cellular calcium homeostasis to combat type 1 diabetes. Here we show that modulation of cellular calcium homeostasis can mitigate cytokine- and ER stress-mediated beta cell death. The calcium modulating compounds, dantrolene and sitagliptin, both prevent cytokine and ER stress-induced activation of the pro-apoptotic calcium-dependent enzyme, calpain, and partly suppress beta cell death in INS1E cells and human primary islets. These agents are also able to restore cytokine-mediated suppression of functional ER calcium release. In addition, sitagliptin preserves function of the ER calcium pump, sarco-endoplasmic reticulum Ca2+-ATPase (SERCA), and decreases levels of the pro-apoptotic protein thioredoxin-interacting protein (TXNIP). Supporting the role of TXNIP in cytokine-mediated cell death, knock down of TXNIP in INS1-E cells prevents cytokine-mediated beta cell death. Our findings demonstrate that modulation of dynamic cellular calcium homeostasis and TXNIP suppression present viable pharmacologic targets to prevent cytokine-mediated beta cell loss in diabetes.Amy L. ClarkKohsuke KanekuraZeno LavagninoLarry D. SpearsDamien AbreuJana MahadevanTakuya YagiClay F. SemenkovichDavid W. PistonFumihiko UranoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Amy L. Clark
Kohsuke Kanekura
Zeno Lavagnino
Larry D. Spears
Damien Abreu
Jana Mahadevan
Takuya Yagi
Clay F. Semenkovich
David W. Piston
Fumihiko Urano
Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
description Abstract Pro-inflammatory cytokines are important mediators of islet inflammation, leading to beta cell death in type 1 diabetes. Although alterations in both endoplasmic reticulum (ER) and cytosolic free calcium levels are known to play a role in cytokine-mediated beta cell death, there are currently no treatments targeting cellular calcium homeostasis to combat type 1 diabetes. Here we show that modulation of cellular calcium homeostasis can mitigate cytokine- and ER stress-mediated beta cell death. The calcium modulating compounds, dantrolene and sitagliptin, both prevent cytokine and ER stress-induced activation of the pro-apoptotic calcium-dependent enzyme, calpain, and partly suppress beta cell death in INS1E cells and human primary islets. These agents are also able to restore cytokine-mediated suppression of functional ER calcium release. In addition, sitagliptin preserves function of the ER calcium pump, sarco-endoplasmic reticulum Ca2+-ATPase (SERCA), and decreases levels of the pro-apoptotic protein thioredoxin-interacting protein (TXNIP). Supporting the role of TXNIP in cytokine-mediated cell death, knock down of TXNIP in INS1-E cells prevents cytokine-mediated beta cell death. Our findings demonstrate that modulation of dynamic cellular calcium homeostasis and TXNIP suppression present viable pharmacologic targets to prevent cytokine-mediated beta cell loss in diabetes.
format article
author Amy L. Clark
Kohsuke Kanekura
Zeno Lavagnino
Larry D. Spears
Damien Abreu
Jana Mahadevan
Takuya Yagi
Clay F. Semenkovich
David W. Piston
Fumihiko Urano
author_facet Amy L. Clark
Kohsuke Kanekura
Zeno Lavagnino
Larry D. Spears
Damien Abreu
Jana Mahadevan
Takuya Yagi
Clay F. Semenkovich
David W. Piston
Fumihiko Urano
author_sort Amy L. Clark
title Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
title_short Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
title_full Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
title_fullStr Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
title_full_unstemmed Targeting Cellular Calcium Homeostasis to Prevent Cytokine-Mediated Beta Cell Death
title_sort targeting cellular calcium homeostasis to prevent cytokine-mediated beta cell death
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/be8e2bac311c4815b5a158b712b3a6a3
work_keys_str_mv AT amylclark targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT kohsukekanekura targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT zenolavagnino targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT larrydspears targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT damienabreu targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT janamahadevan targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT takuyayagi targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT clayfsemenkovich targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT davidwpiston targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
AT fumihikourano targetingcellularcalciumhomeostasistopreventcytokinemediatedbetacelldeath
_version_ 1718393944205688832